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Background
Efforts to relieve the burden caused by malaria rely criti-
cally on the availability of drugs targeting Plasmodium fal-
ciparum. The efficiency of these treatments is however
seriously compromised by the appearance and spread of
drug resistance. Resistance is observed today to some
extent against every available drug, including recent
reports of resistance to artemisinin. Resistant strains of
P. falciparum can spread in affected areas if they fare bet-
ter than sensitive strains over the entire transmission
cycle, including within-human and within-vector infection
phases. Both hosts likely represent widely different envir-
onments for the parasite, particularly in terms of exposure
to drugs and host-specific costs of resistance, which could
notably affect the outcome of competition between resis-
tant and sensitive strains and ultimately the evolution of
drug resistance.
Material and methods
To investigate this issue we present a model of malaria
transmission combining between-hosts and within-hosts
(human and vector) dynamics. The latter incorporates the
impact of competition, treatment and immunity in a
strain-specific fashion.
Results
We show how costs of resistance, particularly within-
vector costs, affect the selection for resistant strains. We
also explore how different drugs, acting on specific parts
of the within-human cycle of P. falciparum, impact resis-
tant strains (alone or in combination). Finally we also
investigate the effect of vector control methods on the pre-
valence of resistance.
Conclusions
Weconclude that the evolution of resistance to antima-
larial drugs is affected by biological specificities of the
parasite across its entire life cycle, including dynamics
within both hosts. Theoretical studies in this framework
that incorporates parasites, humans and mosquitoes
improve our understanding of the emergence and spread
of drug resistance, and provide a better picture to investi-
gate sustainable tools in the fight against malaria.
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